FDA OKs New Cysteine Hydrochloride Product Nouress
Cysteine hydrochloride, critical for treating neonatal patients requiring total parenteral nutrition, remains in short supply in the United States.
Related Articles
Allergic to Your Smartwatch? You’re Not Alone
Contact allergies linked to wearables like smartwatches and earbuds are rising, with nickel and acrylates among the top allergens, a French dermatologist reports.
Are IV Proton Pump Inhibitors Overused in Upper GI Bleeding?
Intravenous proton pump inhibitors are overused in patients with acute upper gastrointestinal bleeding and low-risk or no peptic ulcer disease, with only one third receiving…
Testicular Cancer: EAU
A summary of EAU guidance on testicular cancer; covers diagnosis and treatment and addresses post-pubertal testicular germ-cell tumours
Rucaparib Benefits HRD-Negative Ovarian Cancer Subgroups
Rucaparib maintenance therapy reduced progression risk by 35% in patients with HRD-negative ovarian cancer.
Cutting the Opioid Cord: What’s Next in Acute Pain?
New FDA-approved tools such as cryoanalgesia, sodium-channel blockers, and stimulators are transforming acute pain care and enabling faster, opioid-free recovery, reports Dr Gary Schwartz.
Does Medical Cannabis Alleviate Chronic Pain?
As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality research to guide treatment.
Launched: Early-Stage Hodgkin Lymphoma Prediction Tool
The first prediction tool of its kind for early-stage classic Hodgkin lymphoma provides estimates using continuous variables capturing nonlinear context.
Account for Sex Differences in Severe Aortic Stenosis to Improve Women’s Outcomes
Dr Kayleigh Fox-Gaffney, Dr Alysha Bhatti, Dr Aaysha Cader, Dr Sonya Burgess, Dr Shrilla Banerjee, and Dr Megan Coylewright outline the need for sex-specific recommendations…